Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

<p>Supplementary Table 3 Uni- and multivariate Cox survival analysis using HJURP and NSD2 expression in myeloma dataset</p>

保存先:

書誌詳細
第一著者:	Yunlu Jia (2012017) (author)
その他の著者:	Jianbiao Zhou (14935538) (author), Tze King Tan (15203447) (author), Tae-Hoon Chung (4343) (author), Yongxia Chen (424187) (author), Jing-Yuan Chooi (4238347) (author), Takaomi Sanda (15203450) (author), Melissa J. Fullwood (14195681) (author), Sinan Xiong (6175022) (author), Sabrina H.M. Toh (15203453) (author), Kalpnaa Balan (15203456) (author), Regina W.J. Wong (15203459) (author), Julia S.L. Lim (14935541) (author), Enfan Zhang (9965455) (author), Zhen Cai (576458) (author), Peng Shen (688111) (author), Wee Joo Chng (14959944) (author)
出版事項:	2025
主題:	Cancer Cancer Biology Molecular and Cellular Biology Gene Regulation Mechanisms of transcription Hematological Cancers Myelomas Oncogenes & Tumor Suppressors Oncogenes
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Supplementary Table 1 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
著者:: Yunlu Jia (2012017)
出版事項: (2025)

Supplementary Table 2 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
著者:: Yunlu Jia (2012017)
出版事項: (2025)

Supplementary Table 5 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
著者:: Yunlu Jia (2012017)
出版事項: (2025)

Supplementary Tables S1-14 from Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple <i>PIK3CA</i> Mutations
著者:: Smruthy Sivakumar (15053536)
出版事項: (2025)

Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
著者:: Lijun Yao (15292963)
出版事項: (2025)

Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
著者:: Lijun Yao (15292963)
出版事項: (2025)

Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
著者:: Lijun Yao (15292963)
出版事項: (2025)

Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
著者:: Lijun Yao (15292963)
出版事項: (2025)

Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
著者:: Lijun Yao (15292963)
出版事項: (2025)

Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
著者:: Lijun Yao (15292963)
出版事項: (2025)

Supplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
著者:: Keiji Kurata (15055090)
出版事項: (2025)

Supplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
著者:: Keiji Kurata (15055090)
出版事項: (2025)

Supplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
著者:: Keiji Kurata (15055090)
出版事項: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
著者:: Eileen M. Boyle (15015425)
出版事項: (2025)

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan
著者:: Kazuhito Suzuki (22688384)
出版事項: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
著者:: Feng Wang (44414)
出版事項: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
著者:: Feng Wang (44414)
出版事項: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
著者:: Feng Wang (44414)
出版事項: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
著者:: Feng Wang (44414)
出版事項: (2025)

Supplementary Movie 1 from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
著者:: Jia Liu (15386858)
出版事項: (2025)

Supplementary Tables from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S1 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S1 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S1 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S1 page4 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S2 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S2 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S2 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Figure S3 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
著者:: Craig M. Goodwin (14955973)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3jtpsfmkvrn9osuo86j6p9ngd1